Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

9° Sunny

Site search

Home
News
- Local News
Sports
Obituaries
e-Edition
Classifieds
Explore the Sheyenne
Archives
Best of 2025

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Bristol-Myers Squibb (NY:BMY)

61.09 +0.44 (+0.72%)

Streaming Delayed Price Updated: 2:44 PM EST, Feb 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Bristol-Myers Squibb

< Previous 1 2 3 4 5 6 7 8 9

...

66 67 Next >

Price Over Earnings Overview: Bristol-Myers Squibb ↗

August 18, 2025

Via Benzinga

Greenlight Capital Announces Q2 2025 Trades: New Positions in FLR and VSCO, Exit From VTRS ↗

August 16, 2025

Greenlight Capital, led by David Einhorn, has disclosed its Q2 2025 13F filing trades.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

August 13, 2025

Via Benzinga

Want Over $2,100 in Annual Dividends? Invest $12,000 Into Each of These 3 High-Yielding Stocks ↗

August 13, 2025

The dividend stocks listed below all yield more than 5% and look like safe long-term buys.

Via The Motley Fool

Meta, Microsoft Power Wall Street To New Records Despite Inflation Jump: What's Moving Markets Thursday? ↗

July 31, 2025

A post-earnings surge in Meta Platforms Inc. (NASDAQ:META) and Microsoft Corp.

Via Benzinga

Topics Economy

Earnings Scheduled For July 31, 2025 ↗

July 31, 2025

Via Benzinga

Bristol-Myers Squibb Earnings Preview ↗

July 30, 2025

Via Benzinga

BMY Q2 Deep Dive: Pipeline Progress, Guidance Revision, and Strategic Partnerships Shape Outlook

August 13, 2025

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) announced better-than-expected revenue in Q2 CY2025, but sales were flat year on year at $12.27 billion. The company’s full-year revenue...

Via StockStory

Sanofi, Eli Lilly, Novo Nordisk, AstraZeneca Face Renewed Claims Of Conspiring To Restrict 340B Discounts ↗

August 11, 2025

A federal appeals court revived a lawsuit accusing Sanofi, Eli Lilly, Novo Nordisk, and AstraZeneca of conspiring to restrict 340B drug discounts for safety-net clinics, sending the case back to...

Via Benzinga

Topics Lawsuit

PRME Revenue Misses by 73% ↗

August 07, 2025

Via The Motley Fool

Is It Time to Buy Biotech Stocks? ↗

August 06, 2025

A surge in private market investment has investors wondering: Is it time to bet bigger on biotech?

Via The Motley Fool

RFK Jr. Sued By Eli Lilly, Amgen Over Drug Discount Program ↗

August 06, 2025

Eli Lilly and Amgen are suing HHS over 340B certifications, claiming ineligible clinics cost them millions in lost revenue.

Via Benzinga

Topics Lawsuit

1 Small-Cap Biotech Stock Poised for a Breakout ↗

August 06, 2025

This developmental biotech is nearing a key inflection point.

Via The Motley Fool

Topics Economy

Why Is Replimune Stock Trading Lower On Monday? ↗

August 04, 2025

Replimune stock falls as FDA denies skin cancer drug approval and investors sue over alleged misstatements tied to the IGNYTE trial.

Via Benzinga

BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth ↗

August 04, 2025

BioNTech beat Q2 estimates with higher COVID vaccine revenue and reaffirmed 2025 guidance.

Via Benzinga

This Biotech Stock Could Soar on Upcoming Clinical Data ↗

August 04, 2025

This weight loss drugmaker may be significantly undervalued right now.

Via The Motley Fool

Bristol Myers (BMY) Q2 EPS Jumps 36% ↗

August 01, 2025

Via The Motley Fool

Topics Intellectual Property

Trump Issues 60 Day Ultimatum To US Pharma Giants To Slash Drug Prices: 'If You Refuse To Step Up We Will...' ↗

August 01, 2025

President Donald Trump has issued a 60-day ultimatum to 17 major pharmaceutical companies, demanding that they lower drug prices in the U.S. or face severe consequences.

Via Benzinga

Topics Government

Trump Turns Up Heat On Big Pharma CEOs To Slash Drug Prices Within 60 Days — But Retail Traders Don't Flinch ↗

July 31, 2025

Via Stocktwits

Topics Government

Bristol-Myers Squibb Unusual Options Activity For July 31 ↗

July 31, 2025

Via Benzinga

Why Bristol-Myers Squibb (BMY) Stock Is Trading Lower Today

July 31, 2025

Shares of biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) fell 4.2% in the afternoon session after the company lowered its full-year earnings forecast, overshadowing second-quarter results...

Via StockStory

Topics Intellectual Property World Trade

Bristol-Myers Squibb (NYSE:BMY) Reports Strong Q2, Full-Year Sales Guidance is Optimistic

July 31, 2025

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) announced better-than-expected revenue in Q2 CY2025, but sales were flat year on year at $12.27 billion. The company’s full-year revenue...

Via StockStory

Bristol Myers Cuts Earnings Outlook As Legacy Drugs Face Generic Erosion ↗

July 31, 2025

Bristol Myers beat Q2 sales expectations but cut its 2025 EPS forecast as strategic charges and legacy product declines weighed on earnings.

Via Benzinga

Bristol-Myers Squibb Co (NYSE:BMY) Surpasses Q2 2025 Earnings and Revenue Estimates, Shares Rise in Pre-Market Trading ↗

July 31, 2025

Bristol-Myers Squibb (BMY) beats Q2 2025 revenue and EPS estimates, driving a 2.9% pre-market stock surge. Strong oncology, immunology, and cardiovascular drug sales fuel growth.

Via Chartmill

BRISTOL-MYERS SQUIBB CO (NYSE:BMY) – A High-Yield Dividend Stock with Strong Profitability and Financial Health ↗

July 31, 2025

Bristol-Myers Squibb (BMY) offers a high 5.06% dividend yield, strong profitability, and solid financial health, making it a top pick for income investors. Its undervalued stock and consistent payout...

Via Chartmill

Stock Market Today: S&P 500, Nasdaq To Open Higher After Robust Meta, Microsoft Earnings—Investors Await Apple, Amazon Results ↗

July 31, 2025

U.S. stock futures rose on Thursday after ending on a mixed note on Wednesday. Futures of major benchmark indices were higher, except for the small-cap gauge Russell 2000.

Via Benzinga

Topics Stocks

Dow Falls Over 150 Points After Powell's Comments On Rate Cuts: Investor Sentiment Declines, But Fear Index Remains In 'Greed' Zone ↗

July 31, 2025

US stocks fell on Wednesday, with the Dow dropping over 150 points after Fed Chair Powell's comments. Fear Index remained in Greed zone.

Via Benzinga

Topics Economy Stocks

Microsoft, Apple And 3 Stocks To Watch Heading Into Thursday ↗

July 31, 2025

U.S. stock futures up, Apple, Amazon, Meta report strong earnings, Microsoft beats forecast, Bristol-Myers Squibb to release results.

Via Benzinga

Bristol Myers Squibb: A Stock with Potential Amid Challenges ↗

July 30, 2025

Via The Motley Fool

Got $500? 3 Blue Chip Dividend Stocks to Buy and Hold Forever ↗

July 30, 2025

Being a great investor doesn't have to be complicated or expensive.

Via The Motley Fool

Topics Intellectual Property

< Previous 1 2 3 4 5 6 7 8 9

...

66 67 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Entertainment
Local Events
Sports
Obituaries
Multimedia
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

times-online.com
146 Third St. N.E.
Valley City, ND 58072
Phone: 701-845-0463
Email: vctr@times-online.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Bristol-Myers Squibb (NY:BMY)

Headline News about Bristol-Myers Squibb

Sections

Services

Follow Us